Yüklüyor......
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
BACKGROUND: Diabetic nephropathy (DN) is a lethal diabetic microvascular complication characterized by chronic low-grade inflammation. The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome is implicated in the progression of DN. MCC950 is a selective and potent inhibitor of NL...
Kaydedildi:
| Yayımlandı: | Diabetes Metab Syndr Obes |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684489/ https://ncbi.nlm.nih.gov/pubmed/31447572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S199802 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|